NivolumabPrimary hypothyroidism and secondary adrenal insufficiency: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2039卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72880-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：443 / 443

相关论文

共 50 条

[1] NivolumabPrimary adrenal insufficiency: case report
Reactions Weekly, 2021, 1882 (1) : 377 - 377
[2] Ipilimumab/nivolumabPrimary adrenal insufficiency: case report
Reactions Weekly, 2021, 1874 (1) : 149 - 149
[3] Ipilimumab/nivolumabPrimary adrenal insufficiency: case report
Reactions Weekly, 2020, 1816 (1) : 191 - 191
[4] Ipilimumab/nivolumabPrimary adrenal insufficiency: case report
Reactions Weekly, 2017, 1661 (1) : 182 - 182
[5] NivolumabPrimary hypothyroidism secondary to thyroiditis: case report
Reactions Weekly, 2019, 1746 (1) : 149 - 149
[6] NivolumabHyponatraemia secondary to adrenal insufficiency and hypothyroidism: case report
Reactions Weekly, 2021, 1837 (1) : 524 - 524
[7] Cabozantinib/ipilimumab/nivolumabPrimary adrenal insufficiency: case report
Reactions Weekly, 2020, 1834 (1) : 58 - 58
[8] NivolumabHypophysitis, primary hypothyroidism and secondary adrenal insufficiency: case report
Reactions Weekly, 2018, 1714 (1) : 299 - 299
[9] NivolumabPrimary hypothyroidism: case report
Reactions Weekly, 2020, 1789 (1) : 199 - 199
[10] Ipilimumab/nivolumabPrimary adrenal insufficiency and acute cardiomyopathy: case report
Reactions Weekly, 2022, 1893 (1) : 192 - 192

← 1 2 3 4 5 →